OpenAlex
PricingAboutJobs
Log inGet started
Work

Preliminary clinical investigations of high-dose furmonertinib in NSCLC with EGFR Exon 20 insertions (20ins).

HTML

Year: 2022
Type: conference-abstract
Source: Journal of Clinical Oncology
DOI: 10.1200/jco.2022.40.16_suppl.e21029
Authors: Ying Lin, Zhihuang Hu, Yao Zhang, Si Sun, Hui Yu, Xinmin Zhao, Xianghua Wu, Huijie Wang, Jialei Wang
Institutions: Fudan University Shanghai Cancer Center, Shanghai Medical College of Fudan University, Fudan University
Language: English

Topic: Lung Cancer Treatments and Mutations
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: furmonertinib, EGFR exon 20 insertion, non-small cell lung cancer, third-generation EGFR tyrosine kinase inhibitors, real-world efficacy, adverse events, metastatic lung cancer
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W4281897828
Cites:
Cited by: 2
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security